tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Amylyx Pharmaceuticals’ Phase 3 Study on Avexitide: A Potential Breakthrough for Post-Bariatric Hypoglycemia
PremiumCompany AnnouncementsAmylyx Pharmaceuticals’ Phase 3 Study on Avexitide: A Potential Breakthrough for Post-Bariatric Hypoglycemia
23d ago
Amylyx initiated with a Buy at Guggenheim on ‘blockbuster potential’
Premium
The Fly
Amylyx initiated with a Buy at Guggenheim on ‘blockbuster potential’
1M ago
Amylyx initiated with a Buy at Guggenheim
Premium
The Fly
Amylyx initiated with a Buy at Guggenheim
1M ago
Amylyx initiated with a Buy at TD Cowen
PremiumThe FlyAmylyx initiated with a Buy at TD Cowen
2M ago
Amylyx price target raised to $8 from $7 at Mizuho
Premium
The Fly
Amylyx price target raised to $8 from $7 at Mizuho
2M ago
Positive Buy Rating for Amylyx Pharmaceuticals Inc. Driven by Promising HELIOS Trial Results for AMX0035
Premium
Ratings
Positive Buy Rating for Amylyx Pharmaceuticals Inc. Driven by Promising HELIOS Trial Results for AMX0035
2M ago
Amylyx reports Q1 EPS (42c), consensus (50c)
PremiumThe FlyAmylyx reports Q1 EPS (42c), consensus (50c)
3M ago
Leerink upgrades Amylyx on avexitide growth opportunity
Premium
The Fly
Leerink upgrades Amylyx on avexitide growth opportunity
3M ago
Amylyx upgraded to Outperform from Market Perform at Leerink
Premium
The Fly
Amylyx upgraded to Outperform from Market Perform at Leerink
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100